ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,515Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 180

$1.48M Total Retail Price of All Prescriptions

Rank: 2 out of 180

745 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 745 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 745 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 12,888 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 1,476 771 S3 1 1
LEVOTHYROXINE SODIUM 562 379 2 6
OMEPRAZOLE 537 233 3 2
LISINOPRIL 524 307 4 3
AMLODIPINE BESYLATE 448 315 5 7
METFORMIN HCL 447 211 6 14
POTASSIUM CHLORIDE 445 322 7 13
FUROSEMIDE 424 343 8 5
SIMVASTATIN 375 266 9 9
WARFARIN SODIUM 354 324 10 12
ZOLPIDEM TARTRATE 319 139 11 28
ATENOLOL 290 196 12 35
RANITIDINE HCL 290 110 12 18
HYDROCHLOROTHIAZIDE 290 182 12 19
TRAMADOL HCL 288 99 15 16
TRAZODONE HCL 281 157 16 33
IBUPROFEN 277 80 17 104
GABAPENTIN 267 179 18 10
CARISOPRODOL 261 37 R 19 87
CYMBALTA 260 115 20 58
MELOXICAM 244 182 21 27
PROAIR HFA 233 37 22 59
METOPROLOL TARTRATE 226 156 23 11
CRESTOR 221 139 24 62
MORPHINE SULFATE ER 214 86 S2 25 78
LOVASTATIN 204 116 26 32
FLUOXETINE HCL 202 100 27 71
LYRICA 197 78 28 81
TAMSULOSIN HCL 189 148 29 4
SPIRIVA 184 91 30 74
CARVEDILOL 167 102 31 15
OXYCODONE HCL-ACETAMINOPHEN 163 67 S2 32 75
BUSPIRONE HCL 158 139 33 93
CITALOPRAM HBR 155 116 34 22
DONEPEZIL HCL 151 149 35 34
CELEBREX 149 74 36 124
GLIPIZIDE 141 94 37 86
METOPROLOL SUCCINATE 140 87 38 25
NAMENDA 137 125 39 44
AMITRIPTYLINE HCL 134 44 R 40 57
FENTANYL 130 82 S2 41 107
NAPROXEN 130 59 41 135
ADVAIR DISKUS 129 42 43 72
ATORVASTATIN CALCIUM 128 66 44 39
FLUTICASONE PROPIONATE 127 31 45 30
DIGOXIN 127 116 45 49
CEPHALEXIN 126 86 47 55
TOPIRAMATE 124 39 48 53
OXYCONTIN 124 52 S2 48 119
NEXIUM 119 55 50 54
SULFAMETHOXAZOLE-TRIMETHOPRIM 119 82 50 66
SERTRALINE HCL 117 72 52 46
PREDNISONE 113 65 53 47
DILTIAZEM ER 109 72 54 172
CLONIDINE HCL 109 61 54 67
ISOSORBIDE MONONITRATE ER 97 76 56 26
SINGULAIR 97 23 56 105
ROPINIROLE HCL 96 40 58 82
CLOPIDOGREL 96 66 58 24
NIASPAN 92 23 60 194
ENDOCET 91 22 S2 61 122
CYCLOBENZAPRINE HCL 89 0 R 62 60
PREMARIN 88 56 R 63 101
JANUVIA 87 39 64 97
LANTUS 86 54 65 37
LIDODERM 86 50 65 154
PANTOPRAZOLE SODIUM 85 32 67 40
FINASTERIDE 84 78 68 8
QUETIAPINE FUMARATE 83 59 69 94
ALLOPURINOL 80 57 70 43
PAROXETINE HCL 78 33 71 113
AVODART 75 63 72 42
TRICOR 74 33 73 200
OXYCODONE-ACETAMINOPHEN 74 38 S2 73 73
GLYBURIDE 74 40 R 73 244
TRIAMTERENE-HCTZ 73 63 76 88
TRIAMCINOLONE ACETONIDE 73 39 76 56
SAVELLA 72 45 78 288
OXYCODONE HCL 72 27 S2 78 84
PROMETHAZINE HCL 71 45 R 80 195
ESTRADIOL 71 52 R 80 100
PATADAY 69 53 82 291
PROPRANOLOL HCL 68 45 83 182
PLAVIX 67 41 84 38
MIRTAZAPINE 67 61 84 48
NITROFURANTOIN MONO-MACRO 67 60 84 118
ENALAPRIL MALEATE 64 37 87 98
ARICEPT 64 53 87 297
METHADONE HCL 63 0 S2 89 155
INSULIN SYRINGE 62 18 90 102
NITROSTAT 61 37 91 159
LABETALOL HCL 61 27 91 233
DIVALPROEX SODIUM 61 53 91 120
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 25 94 141
DIOVAN 59 44 95 96
AMOX TR-POTASSIUM CLAVULANATE 57 36 96 210
VERAPAMIL ER 57 25 96 238
COMBIVENT 57 16 96 170
DOXYCYCLINE HYCLATE 56 23 99 45
SYMBICORT 56 30 99 127
JANUMET 55 39 101 320
SYNTHROID 55 24 101 178
TIZANIDINE HCL 54 18 103 136
ALENDRONATE SODIUM 54 30 103 76
MORPHINE SULFATE 53 15 S2 105 139
ONGLYZA 53 29 105 220
OXYBUTYNIN CHLORIDE 52 27 107 82
LOVAZA 52 22 107 192
ANDROGEL 52 39 S3 107 259
LIPITOR 51 30 110 196
LOSARTAN POTASSIUM 51 40 110 23
LITHIUM CARBONATE 51 34 110 342
TRILIPIX 51 16 110 342
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.